dc.date.accessioned2023-12-05T17:48:01Z
dc.date.accessioned2024-04-24T13:25:58Z
dc.date.available2023-12-05T17:48:01Z
dc.date.available2024-04-24T13:25:58Z
dc.date.created2023-12-05T17:48:01Z
dc.date.issued2023
dc.identifierhttps://hdl.handle.net/20.500.12866/14643
dc.identifierhttps://doi.org/10.1126/science.adj0070
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9231871
dc.description.abstractDuring the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)–1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.
dc.languageeng
dc.publisherAmerican Association for the Advancement of Science
dc.relationScience
dc.relation1095-9203
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectSARS-CoV-2
dc.subjectAntigenic
dc.subjectSerological
dc.titleMapping SARS-CoV-2 antigenic relationships and serological responses
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución